Rebus Pharmaceutical Llp - Company Profile

It is a pharma limited liability partnership based in Kolkata, West Bengal, India, established in 2016.
2016 Kolkata, West Bengal, India Active
Last Updated:
Access Report
About Rebus Pharmaceutical Llp

Rebus Pharmaceutical Llp, a active limited liability partnership, was established on 09 June 2016 in Kolkata, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds LLPIN: AAG-6149. Registered under ROC Roc Kolkata. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Bina Rajkumar Damani (Designated Partner), Mayank Raj Kumar Damani (Designated Partner). Its latest date of accounts and solvency statement 31 March 2025. It is based at 28/1/A Ratan Sarkar Garden Street, Kolkata, West Bengal, 700007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAG-6149

  • Incorporation Date

    09 June 2016

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Kolkata

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 9 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Rebus Pharmaceutical Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Rebus Pharmaceutical Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rebus Pharmaceutical Llp?
Current Designated Partners
Name Designation Appointment Date Status
Bina Rajkumar Damani Designated Partner 09 Jun 2016 Current
Mayank Raj Kumar Damani Designated Partner 09 Jun 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rebus Pharmaceutical Llp.

Enhance accessibility to Rebus Pharmaceutical Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Rebus Pharmaceutical Llp revenue growth over time
Rebus Pharmaceutical Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rebus Pharmaceutical Llp?

Unlock access to Rebus Pharmaceutical Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rebus Pharmaceutical Llp?

Unlock and access historical data on people associated with Rebus Pharmaceutical Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rebus Pharmaceutical Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rebus Pharmaceutical Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rebus Pharmaceutical Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Rebus Pharmaceutical Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Rebus Pharmaceutical Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata. was recorded as a recent event.

  • Director Appointment

    Progress on Bina Rajkumar Damani was appointed as a Designated Partner was appointed as a Designated Partner on 09 Jun 2016 & has been associated with this company since 9 years 10 months . was documented.

  • Director Appointment

    Mayank Raj Kumar Damani was appointed as a Designated Partner was appointed as a Designated Partner on 09 Jun 2016 & has been associated with this company since 9 years 10 months . was recorded as a recent event.

  • LLP Incorporation

    Rebus Pharmaceutical Llp was registered on 09 Jun 2016 with Roc Kolkata & aged 9 years 10 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Rebus Pharmaceutical Llp?

The LLPIN of Rebus Pharmaceutical Llp is AAG-6149.

Where is Rebus Pharmaceutical Llp headquartered?

Rebus Pharmaceutical Llp is headquartered at 28/1/A Ratan Sarkar Garden Street, Kolkata, West Bengal, 700007.

When was Rebus Pharmaceutical Llp incorporated?

Rebus Pharmaceutical Llp was incorporated on 09 June 2016.

Who are the current directors of Rebus Pharmaceutical Llp?

The current directors of Rebus Pharmaceutical Llp are

What is the primary industry of Rebus Pharmaceutical Llp?

The primary industry of Rebus Pharmaceutical Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available